Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2016 / Dec / Canada’s Quality Commitment
Quality assurance and quality control Regulation and standards Laboratory management Profession Professional Development

Canada’s Quality Commitment

Canada publishes its first ever guidelines for interpretive pathology

By William Aryitey 12/15/2016 1 min read

Share

For Canadian pathologists, this year’s International Pathology Day brought more than just a celebration of their work. The pioneering release of quality framework recommendations for interpretive pathology (1) by the Canadian Partnership Against Cancer (CPAC) and Canadian Association of Pathologists – Association Canadienne des Pathologistes (CAP-ACP).

Unlike other regions such as the US and UK, this framework is the first of its kind for Canada. According to John Srigley, expert lead of pathology and Chair of CPAC’s National Pathology Standards Committee, Canada’s pathology practices have been called into question over the last decade (2), and as a result, there has been a growing need for a unified set of recommendations. Those guidelines, says CAP-ACP President Victor Tron, are meant to inform interpretive pathology quality across Canada for practicing pathologist groups, hospitals, and provincial authorities.

The document conceptualizes the pathology testing cycle in three phases:

  • the pre-interpretive, where pathologists assess specimen IDs, clinical information, quality of gross description, and the quality of slides. 
  • the interpretive, where pathologists analyze case materials. 
  • the post-interpretive, where pathologists maintain report accuracy, timeliness, and proper completion, as well as delivering the report to the reporting physician.

It also explains the quality assurance specifics, oversight, and informatics involved in each phase of the process. To create the most informed document on best practices, the country’s leading pathologists were engaged – but Srigley emphasizes that the published framework is not a static document; the plan is to update it every two to three years so that the guidelines can evolve alongside Canadian pathology practice.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. Cancerview.ca, “Pan-Canadian quality assurance recommendations for interpretive pathology”, (2016). Available at: http://bit.ly/2gTDj0w. Accessed December 7, 2016. Cancerview.ca, “Interpretive pathology quality”, (2016). Available at: http://bit.ly/2h9zpPh. Accessed December 8, 2016.

About the Author(s)

William Aryitey

My fascination with science, gaming, and writing led to my studying biology at university, while simultaneously working as an online games journalist. After university, I travelled across Europe, working on a novel and developing a game, before finding my way to Texere. As Associate Editor, I’m evolving my loves of science and writing, while continuing to pursue my passion for gaming and creative writing in a personal capacity.

More Articles by William Aryitey

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

R-Tracker: The First of Its Kind
Quality assurance and quality control
R-Tracker: The First of Its Kind

December 29, 2021

1 min read

Milestone is committed to enhancing patient safety with a new disruptive technology

The Big Freeze
Quality assurance and quality control
The Big Freeze

February 7, 2022

1 min read

Cryobioprinting could maximize the shelf life of bioprinted 3D tissues

Biospecimen Access For Biotechs
Quality assurance and quality control
Biospecimen Access For Biotechs

February 14, 2022

1 min read

Quality, provenance, and “taking pot luck”

Questions of Quality
Quality assurance and quality control
Questions of Quality

October 21, 2016

1 min read

The importance of quality is broadly accepted – witness the plethora of standards and guidelines – but do they lead to effective implementation?

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.